AMIX: SEC Form S-3 filed by Autonomix Medical Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for AMIX
Across the 28 sessions after earlier AMIX headlines, the stock closed higher 12 times and lower 16 times, with a median move of 5.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | AMIX | SPY |
|---|---|---|---|
| Sep 1, 2026 | Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026 | -1.9% | -0.7% |
| Aug 26, 2026 | Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery | -11.3% | +0.0% |
| Aug 25, 2026 | Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules | +33.9% | +0.3% |
| Aug 12, 2026 | Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission | -17.4% | +0.3% |
| Aug 10, 2026 | Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award | -7.5% | -0.0% |
| Jul 24, 2026 | Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study | -16.6% | +0.1% |
Quantisnow market dataNASDAQ
AMIX
Autonomix Medical Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2024
Get push alerts for AMIX
Full AMIX profile on Quantisnow Follow AMIX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time